Else Nutrition Holdings Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-15
Else Nutrition Reports First Quarter 2026 Results Highlighting Significant Improvement in Gross Margin and Reduced Net Loss
News release - English.pdf
Results 2026-05-15
Interim MD&A - English.pdf
Results 2026-05-15
Interim financial statements/report – English.pdf
News 2026-04-15
Else Nutrition Commends Trump Administration's Expanded Commitment to Bolstering Infant Formulas Regulation in FY2027
News release - English.pdf
Results 2026-03-31
Else Nutrition Reports Fiscal Year 2025 Financial Results and Highlights Operational Progress, Strengthened Financial Foundation, and Clear Path Toward Profitability
News release - English.pdf
Results 2026-03-31
Annual MD&A - English.pdf
Results 2026-03-31
Audited annual financial statements – English.pdf
Results 2026-03-31
Annual information form - English.pdf
News 2026-03-10
Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards
News release - English.pdf
Results 2026-01-29
Else Nutrition Surpasses One Million Cans Sold Since Launch
News release - English.pdf
News 2026-01-07
Else Nutrition Plans Canadian Market Relaunch in 2026
News release - English.pdf
Results 2025-12-17
Else Nutrition Achieves Transformative Operational and Financial Progress in 2025
News release - English.pdf
News 2025-12-08
Other.pdf
News 2025-12-02
Else Nutrition Secures Five-Year Renewal of Israel's Largest Health Fund Tender for Baby Feeding Solutions
News release - English.pdf
News 2025-11-29
Report of exempt distribution (45-106F1).pdf
Transactions 2025-11-28 Financing
Else Nutrition Enters Into Convertible Securities Funding Agreement for Gross Proceeds of up to US$1,280,000
Material change report - English.pdf
Transactions 2025-11-24 Financing
ELSE ANNOUNCES INVESTMENT FOR GROSS PROCEEDS OF UP TO US$1,280,000
News release - English.pdf
News 2025-11-18
Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula
News release - English.pdf
Results 2025-11-14 Financials
Interim MD&A - English.pdf
Results 2025-11-14 Financials
Interim financial statements/report – English.pdf
News 2025-11-14
News release - English.pdf
Results 2025-11-14 Financials
Interim MD&A - English.pdf
Results 2025-11-14 Financials
Interim financial statements/report – English.pdf
News 2025-11-14
News release - English.pdf
News 2025-11-13
News release - English.pdf
News 2025-11-07
Material change report - English.pdf
News 2025-11-03
News release - English.pdf
News 2025-09-16
News release - English.pdf
News 2025-09-11
News release - English.pdf
Results 2025-09-11 Financials
Interim MD&A - English.pdf
Results 2025-09-11 Financials
Interim financial statements/report – English.pdf
Results 2025-08-21 Financials
Interim financial statements/report – English.pdf
News 2025-08-21
News release - English.pdf
Results 2025-08-21 Financials
Interim MD&A - English.pdf
News 2025-08-19
News release - English.pdf
News 2025-08-01
News release - English.pdf
News 2025-07-22
News release - English.pdf
News 2025-06-26
Material change report - English.pdf
News 2025-06-19
News release - English.pdf
News 2025-06-10
News release - English.pdf
News 2025-06-02
News release - English.pdf
Results 2025-06-02 Financials
Annual MD&A - English.pdf
Results 2025-06-02 Financials
Annual information form - English.pdf
Results 2025-06-02 Financials
Audited annual financial statements – English.pdf